Table 4.
Study | Design | Characteristics of the sample | Major findings |
Pietroff et al. (2001) | • Retrospective, questionnaire – based inquiry, comparing those with (25%) and without PSA recurrence, an average 3 years post-surgery • UCLA Prostate Cancer Index and the RAND 36-item Health Survey used |
• 348 patients with localized disease | • Small difference only on QOL between the 2 groups; generally, men well adjusted • PSA-recurrence group, unexpectedly had higher scores on emotional well-being |
Rosetti and Terrone (1996) | • Retrospective inquiry (EORTC) 1 – 15 years after RP | • 161 patients, of whom "over 80%" did not have metastases | • Minimal overall psychological impact • 90% satisfied with surgery, and would opt to have it again |
Heathcote et al. (1998) | • Retrospective inquiry 1–6 years after surgery • QOL measure constructed by authors |
• 140 patients who had no evidence of recurrent or residual disease | • 90% satisfied with treatment, despite impotence in 40% of sample |
Meyer et al. (2003) | • Retrospective inquiry (ED – QOL)a median 7 years after surgery | • 89 patients with localized disease | • Most patients felt adverse effects, including anger, guild and sadness associated with impotence. • 75% of men had lowered self-esteem to some degree |
Ficarra et al. (2000) | • Retrospective inquiry an average 2 years after surgery; inclusion of control group of men who had RP for benign prostatic hyperplasia. • General Health Questionnaire and the Hospital Depression and Anxiety Scale |
• 30 patients with localized disease | • Cancer patients had significantly higher levels of anxiety • Depression levels similar in 2 groups; minimal in each group |
Randorf-Klym and Colling (2003) | • Retrospective inquiry 1–2 years following surgery • QOL measure constructed by authors |
• 88 patients | • Perceived social support, self-esteem and health locus of control predicted post-surgery QOL • Suppression of anger and depression non-predictors |